Dimitrios Kouvelas, PhD, has replaced Aikaterini Moraiti, PhD
Dimitrios Kouvelas, PhD, has replaced Aikaterini Moraiti, PhD, as Greece’s new member of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency.
Kouvelas is a professor of pharmacology and clinical pharmacology at the Aristotle School of Medicine, University of Thessaloniki, and a visiting professor of pharmacology and clinical pharmacology, University Svetozar Markovic Medical Faculty, Kraguijevac, Serbia. His research fields include neuro/psychopharmacology, neuro-transmission, clinical pharmacology and rational prescribing.
Moraiti has been a member of the CHMP since 2012, and is a scientific expert for Greece’s National Organization of Medicines and a member of the Greek Committee for Orphan Medicines.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Novel Agent Shows Superiority Over Placebo in Reducing Monthly Migraine Days
September 5th 2024Lu AG09222 shows promise as first-in-class medication that prevents neurogenic inflammation, vasodilation, and parasympathetic lacrimation, which are considered to be surrogate markers of migraine attacks.